These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 619931)
1. Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease. Jennings K; Jackson PG; Monaghan M; Jewitt DE Br J Clin Pharmacol; 1978 Jan; 5(1):13-8. PubMed ID: 619931 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease. Hutton I; Hillis WS; Langhan CE; Conely JM; Lawrie TD Br J Clin Pharmacol; 1977 Oct; 4(5):513-7. PubMed ID: 911601 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of new inotropic drugs in clinical coronary heart failure. Jewitt D; Jennings K; Jackson PG Am J Med; 1978 Jul; 65(1):197-202. PubMed ID: 685994 [No Abstract] [Full Text] [Related]
4. Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs. Van de Water A; d'Aubioul J; Van Gerven W; de Chaffoy de Courcelles D; Freyne E; Xhonneux R; Reneman RS; Janssen PA Arch Int Pharmacodyn Ther; 1992; 316():60-74. PubMed ID: 1530374 [TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats. Nekooeian AA; Tabrizchi R Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898 [TBL] [Abstract][Full Text] [Related]
6. Haemodynamic effects of R 80122 immediately after cardiopulmonary bypass; preliminary results. Herregods L; Rolly G; Van Belleghem Y; Van Nooten G Anaesthesia; 1994 Aug; 49(8):719-22. PubMed ID: 7943708 [TBL] [Abstract][Full Text] [Related]
7. The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man. Jackson PG; Jackson G; Kitson D; Jewitt DE Br J Clin Pharmacol; 1978 Jan; 5(1):7-11. PubMed ID: 619936 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease. Legrand V; Vandormael M; Collignon P; Kulbertus HE Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856 [TBL] [Abstract][Full Text] [Related]
9. Effects of R80122, a new phosphodiesterase inhibitor, on liver and global haemodynamics in patients undergoing coronary artery bypass surgery. Autschbach R; Lange H; Stephan H; Mohr FW; Becker B; Sonntag H Cardiovasc Surg; 1994 Dec; 2(6):698-702. PubMed ID: 7858987 [TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of dobutamine in patients with coronary artery disease. Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and haemodynamic effects of a new inotropic agent (UK14275) in the dog. Russell DC; Smith HJ; Oliver MF Clin Exp Pharmacol Physiol; 1979; 6(5):585-9. PubMed ID: 498597 [TBL] [Abstract][Full Text] [Related]
12. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?]. Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699 [TBL] [Abstract][Full Text] [Related]
13. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone. Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538 [TBL] [Abstract][Full Text] [Related]
14. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat. Nekooeian AA; Tabrizchi R Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574 [TBL] [Abstract][Full Text] [Related]
15. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease. Atkins CE; Keene BW; McGuirk SM; Sato T Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418 [TBL] [Abstract][Full Text] [Related]
16. The negative inotropic and chronotropic effects of intravenous R 56865 during percutaneous transluminal coronary angioplasty. Pijl AJ; Van Wezel HB; Koolen JJ; Piek JJ; Koch K; Swaan A; David GK; Visser CA; Van Zwieten PA Br J Clin Pharmacol; 1995 May; 39(5):531-5. PubMed ID: 7669490 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic effects of intravenous injections of amiodarone chlorhydrate in normal subjects and coronary patients]. Ourbak P; Rocher R; Aziza JP; Manin JP; Vagner D; Leclerc M; Maurice P Arch Mal Coeur Vaiss; 1976 Mar; 69(3):293-8. PubMed ID: 828014 [TBL] [Abstract][Full Text] [Related]